General MedicationsORALStandard
OJJAARA
MOMELOTINIB DIHYDROCHLORIDE
Standard Dose
EQ 100MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OJJAARA is listed in Drugs@FDA under application 216873 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MOMELOTINIB DIHYDROCHLORIDE Form and strength TABLET;ORAL - EQ 100MG BASE Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2026-03-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview OJJAARA is listed in Drugs@FDA under application 216873 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MOMELOTINIB DIHYDROCHLORIDE Form and strength TABLET;ORAL - EQ 100MG BASE Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.